QT Imaging Returns to Nasdaq After Delisting Reversal
Event summary
- QT Imaging uplisted from OTCQB to Nasdaq Capital Market, effective January 28, 2026.
- Company met Nasdaq’s financial, governance, and regulatory listing requirements.
- Shares will trade under new ticker symbol “QTI” after less than one year delisted.
- CEO Dr. Raluca Dinu cited operational turnaround and balance sheet restructuring as key milestones.
The big picture
The uplisting marks a strategic rebound for QT Imaging, aligning with its goal of expanding global reach for radiation-free breast imaging. While Nasdaq listing enhances credibility, the company must now prove its technology can scale beyond development. The medical imaging sector increasingly values patient-centric, non-invasive solutions, positioning QT Imaging to capitalize on this trend if execution holds.
What we're watching
- Execution Risk
- Whether QT Imaging can sustain momentum after rapid turnaround and maintain Nasdaq listing requirements.
- Market Access
- How Nasdaq visibility impacts investor base expansion and long-term value creation.
- Commercialization Pace
- The speed at which QT Imaging advances its Breast Acoustic CT technology from lab to clinical adoption.
Related topics